← All trials
NCT02012387
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2014
- Primary completion
- Sep 1, 2016
- Completion date
- Jun 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 24
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Clinica Universidad de NavarraLead sponsor
- Hospital General Universitario Gregorio MarañonCollaborator
- Hospital Universitario Central de AsturiasCollaborator
- University of BarcelonaCollaborator
- Clinica Universidad de NavarraCollaborator
- Universidad Autonoma de BarcelonaCollaborator
- Hospital Joan XXIII de Tarragona, Tarragona, SpainCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.